Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Lupin gets USFDA nod for generic version of Mycobutin capsules - The Pharma Times | Pharma & Health Care News Portal
Categories: US FDA Approval

Lupin gets USFDA nod for generic version of Mycobutin capsules

The drug is used for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection

New Delhi February 28, 2014:- Pharmaceutical firm Lupin Ltd. on Wednesday said it has received final approval from the US health regulator to market the generic version of Mycobutin capsules of Pharmacia and Upjohn Co. that are used while treating advance HIV infection.
The approval from the US Food and Drug Administration (FDA) is forRifabutin Capsules USP, in strength of 150 mg, said Lupin in a statement.
“Lupin Pharmaceuticals Inc. (LPI), the company’s US subsidiary would commence marketing the product shortly,” it said further.
The drug is used for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.

Lupin’s Rifabutin capsules are generic equivalent of Pharmacia and Upjohn Co.’s Mycobutin capsules. Headquartered in Baltimore, Maryland, Lupin is the 5th largest generics player in the US and third in Japan and South Africa. PTI 

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

4 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

6 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago